ICL Group Ltd, together with its subsidiaries, operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Growing Solutions. The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; produces various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based products. The Potash segment extracts potash from the Dead Sea; mines and produces potash and salt; produces polysulphate; produces, markets, and sells magnesium and magnesium alloys, as well as related by-products, including chlorine and sylvinite; and sells salt. This segment uses phosphate commodity products to produce specialty products; produces and markets phosphate-based fertilizers, as well as sulphuric acid, green phosphoric acid, and phosphate fertilizers; and offers Phosphate salts and acids for various industrial end markets, such as oral care, cleaning products, paints and coatings, water treatment, asphalt modification, construction, and metal treatment. It also develops and produces functional food ingredients and phosphate additives for use in the processed meat, poultry, seafood, dairy, beverage, and baked goods markets; and produces milk and whey proteins for the food ingredients industry. The Growing Solutions segment develops, manufactures, markets, and sells fertilizers based primarily on nitrogen, potash, and phosphate, including water soluble specialty, liquid, soluble, and controlled-release fertilizers. It sells its products through marketing companies, agents, and distributors. The company was formerly known as Israel Chemicals Ltd. and changed its name to ICL Group Ltd in May 2020. The company was incorporated in 1968 and is headquartered in Tel Aviv, Israel.

ICL Group Ltd.

HICL Infra Co Shs GBP ( ($GB:HICL) ) just unveiled an announcement. HICL Infrastructure PLC has rescheduled the announcement of its Interim Results...

HICL Infrastructure PLC Reschedules Interim Results Announcement

Barclays analyst Benjamin Theurer maintained a Hold rating on Icl today and set a price target of $6.00. According to TipRanks, Theurer is a 3-star...

Icl (ICL) Receives a Hold from Barclays

Greenfirst Forest Products Inc. (($TSE:GFP)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call f...

GreenFirst Faces Challenges Amid Earnings Call Insights

An announcement from HICL Infra Co Shs GBP ( ($GB:HICL) ) is now available. HICL Infrastructure PLC has announced the purchase of 524,518 of its ow...

HICL Infrastructure PLC Executes Share Buyback

Peel Hunt analyst reiterated a Hold rating on Nichols today and set a price target of p1,300.00. The analyst consensus on Nichols is currently a Ho...

Peel Hunt Sticks to Its Hold Rating for Nichols (NICL)

Berenberg Bank analyst reiterated a Buy rating on Nichols today and set a price target of p1,820.00. The analyst consensus on Nichols is currently ...

Berenberg Bank Keeps Their Buy Rating on Nichols (NICL)

The latest announcement is out from Class 1 Nickel & Technologies ( ($TSE:NICO) ). Green Panda Capital Corp., a company listed on the TSX Venture E...

Green Panda Capital Corp. Announces Private Placement and Leadership Change

An announcement from Iceni Gold Ltd. ( ($AU:ICL) ) is now available. Iceni Gold Limited announced a change in the interest of its director, Brian R...

Iceni Gold Director Increases Shareholding

HICL Infra Co Shs GBP ( ($GB:HICL) ) has shared an update. HICL Infrastructure PLC, a company involved in infrastructure investments, has announced...

HICL Infra Co Shs GBP ( ($GB:HICL) ) just unveiled an announcement. HICL Infrastructure PLC has announced a share buyback transaction, purchasing 5...

HICL Infrastructure Executes Share Buyback Programme

Analysts have been eager to weigh in on the Healthcare sector with new ratings on BioNTech SE (BNTX – Research Report), Icon (ICLR – Research Repor...

Analysts Conflicted on These Healthcare Names: BioNTech SE (BNTX), Icon (ICLR) and Innovent Biologics (OtherIVBXF)

In a report released yesterday, Elizabeth Anderson CFA from Evercore ISI maintained a Buy rating on Icon, with a price target of $240.00. The compa...

Icon (ICLR) Gets a Buy from Evercore ISI

Iceni Gold Ltd. ( ($AU:ICL) ) has issued an announcement. Iceni Gold Ltd. has announced the details of its upcoming Annual General Meeting of share...

Iceni Gold Ltd. Announces Details for Upcoming Annual General Meeting

Icon ( ($ICLR) ) has issued an update. ICON plc announced a leadership transition with Dr. Steve Cutler retiring as CEO on October 1, 2025, succeed...

Current Quarter	$0.11	Next Quarter	$NA
Current Year	$0.37	Next Year	$0.45
QoQ Growth	NaN%	YoY Growth	+21.6%
3Y EPS CAGR	-19.4%	Target Price	$6.44
Consensus	Buy	Upside	+19.5%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ICL	$5.39	+2.08%	929.10K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ICL	$5.39	+2.1%	929.10K
3
4
5
6

ICL

ICL

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get ICL Group Ltd. Data in Excel

Get ICL Group Ltd. Data in Excel